Akanda Corp. (AKAN)

USD 1.16

(5.45%)

Total Debt Summary of Akanda Corp.

  • Akanda Corp.'s latest annual total debt in 2023 was 3.99 Million USD , up 2.54% from previous year.
  • Akanda Corp.'s latest quarterly total debt in 2024 Q2 was 374.41 Thousand USD , down 0.0% from previous quarter.
  • Akanda Corp. reported annual total debt of 3.89 Million USD in 2022, down -59.24% from previous year.
  • Akanda Corp. reported annual total debt of 9.56 Million USD in 2021, up 4.87% from previous year.
  • Akanda Corp. reported quarterly total debt of 5.18 Million USD for 2023 Q2, up 4.54% from previous quarter.
  • Akanda Corp. reported quarterly total debt of 3.99 Million USD for 2023 FY, up 2.54% from previous quarter.

Annual Total Debt Chart of Akanda Corp. (2023 - 2019)

Historical Annual Total Debt of Akanda Corp. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 3.99 Million USD 2.54%
2022 3.89 Million USD -59.24%
2021 9.56 Million USD 4.87%
2020 9.12 Million USD 0.0%
2019 - USD 0.0%

Peer Total Debt Comparison of Akanda Corp.

Name Total Debt Total Debt Difference
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.407%
Embecta Corp. 1.63 Billion USD 99.756%
ANI Pharmaceuticals, Inc. 315.32 Million USD 98.732%
Dynavax Technologies Corporation 256.91 Million USD 98.444%
Esperion Therapeutics, Inc. 540.94 Million USD 99.261%
Pacira BioSciences, Inc. 586.04 Million USD 99.318%
PainReform Ltd. 86 Thousand USD -4549.757%
Aquestive Therapeutics, Inc. 98.82 Million USD 95.954%
Sunshine Biopharma, Inc. 657.7 Thousand USD -507.992%
SCYNEXIS, Inc. 15.08 Million USD 73.483%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -51.043%
Cosmos Health Inc. 12.42 Million USD 67.814%
Journey Medical Corporation 17.73 Million USD 77.446%
Sunshine Biopharma, Inc. 657.7 Thousand USD -507.992%
Safety Shot Inc 1.54 Million USD -158.157%
Alpha Teknova, Inc. 30.45 Million USD 86.871%
Intra-Cellular Therapies, Inc. 16.93 Million USD 76.392%
Bright Green Corporation 1.85 Million USD -115.943%
Procaps Group, S.A. 285.93 Million USD 98.602%
Theratechnologies Inc. 58.96 Million USD 93.219%
Harrow Health, Inc. 190.5 Million USD 97.901%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -557.696%
Biofrontera Inc. 5.39 Million USD 25.935%
DURECT Corporation 20.74 Million USD 80.725%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 90.371%
Cronos Group Inc. 2.53 Million USD -57.437%
OptiNose, Inc. 131.74 Million USD 96.965%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.441%
Kala Pharmaceuticals, Inc. 36.32 Million USD 88.991%
RedHill Biopharma Ltd. 1.17 Million USD -240.901%
Organogenesis Holdings Inc. 119.35 Million USD 96.65%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 78.301%
Radius Health, Inc. 365.31 Million USD 98.905%
Universe Pharmaceuticals INC 5.48 Million USD 27.062%
ProPhase Labs, Inc. 21.38 Million USD 81.297%
Phibro Animal Health Corporation 525.45 Million USD 99.239%
Procaps Group S.A. 285.93 Million USD 98.602%
Alvotech 1.07 Billion USD 99.628%
TherapeuticsMD, Inc. 8 Million USD 50.046%
Viatris Inc. 18.12 Billion USD 99.978%
Rockwell Medical, Inc. 13.43 Million USD 70.245%
Aytu BioPharma, Inc. 15.12 Million USD 73.569%
SIGA Technologies, Inc. 1.46 Million USD -173.14%
Tilray Brands, Inc. 387.31 Million USD 98.968%
Lifecore Biomedical, Inc. 130.36 Million USD 96.933%
Shineco, Inc. 29.65 Million USD 86.516%
PetIQ, Inc. 468.3 Million USD 99.146%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -6586.159%
Incannex Healthcare Limited 373 Thousand USD -972.062%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.067%
Alimera Sciences, Inc. 67.39 Million USD 94.067%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 40.91 Million USD 90.226%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -267.639%
Petros Pharmaceuticals, Inc. 8.27 Million USD 51.686%
Clever Leaves Holdings Inc. 2.08 Million USD -91.605%
Cyclo Therapeutics, Inc. 1.03 Million USD -287.062%
Avadel Pharmaceuticals plc 35.38 Million USD 88.699%
Hempacco Co., Inc. 13.72 Million USD 70.864%
Talphera, Inc. - USD -Infinity%
Alvotech 1.07 Billion USD 99.628%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 93.598%
Lantheus Holdings, Inc. 616.94 Million USD 99.352%
Currenc Group, Inc. 31.94 Million USD 87.482%
Kamada Ltd. 8.74 Million USD 54.294%
Indivior PLC 281.6 Million USD 98.58%
Evoke Pharma, Inc. 5 Million USD 20.024%
Flora Growth Corp. 3.67 Million USD -8.9%
Cyclo Therapeutics, Inc. 1.03 Million USD -287.062%
Evolus, Inc. 126.54 Million USD 96.84%
HUTCHMED (China) Limited 86.13 Million USD 95.357%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.359%